Proscia Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 46
Employees
  • Latest Deal Type
  • 2ndary - Private
  • Investors
  • 14

Proscia General Information

Description

Developer of a digital pathology platform designed to perfect cancer diagnosis and change the way the world practices pathology. The company's platform uses computing technologies that unlock hidden data not visible to the human eye and turns that data into valuable insights, enabling physicians to improve patient outcomes and accelerate the development of life-saving advances.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Technology Systems
Discovery Tools (Healthcare)
Primary Office
  • 1635 Market Street
  • Suite 1307
  • Philadelphia, PA 19103
  • United States
+1 (877) 000-0000

Proscia Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Proscia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Secondary Transaction - Private 000.00 Completed Generating Revenue
8. Later Stage VC (Series B) 30-Nov-2020 0000 000.00 0000 Completed Generating Revenue
7. Debt - PPP 10-Apr-2020 000.00 Completed Generating Revenue
6. Early Stage VC (Series A) 17-Oct-2018 00.000 000.00 000.00 Completed Generating Revenue
5. Seed Round 08-May-2017 00000 00.000 00.000 Completed Generating Revenue
4. Seed Round 05-Jul-2016 000 00.000 000 Completed Generating Revenue
3. Angel (individual) 00.000 00.000 Completed Startup
2. Grant 03-Apr-2015 $10K $70K Completed Startup
1. Capitalization 01-Jul-2014 $70K $70K Completed Startup
To view Proscia’s complete valuation and funding history, request access »

Proscia Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Seed 1 1,172,200 $0.001000 $0.79 $0.79 1x $0.79 5.44%
Seed 1,940,800 $0.001000 $0.56 $0.56 1x $0.56 9%
To view Proscia’s complete cap table history, request access »

Proscia Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a digital pathology platform designed to perfect cancer diagnosis and change the way the world practices pa
Decision/Risk Analysis
Philadelphia, PA
46 As of 2021
000.00
000000 - 000 000.00

00000000

rit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidata
0000000000000
Tampa, FL
00 As of 0000
000000000 -

00000000

met, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
0000000000000 00000000
La Jolla, CA
00 As of 0000
000000000 -
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Proscia Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Inspirata Corporation Tampa, FL 00 000000000 -
0000000000 Venture Capital-Backed La Jolla, CA 00 000000000 -
000000 Venture Capital-Backed Boston, MA 000 0000 00000000000 0000
0000000 Venture Capital-Backed San Francisco, CA 00 0000 00000000000 0000
00000 Venture Capital-Backed New York, NY 00 00000 00000000000 00000
You’re viewing 5 of 12 competitors. Get the full list »

Proscia Executive Team (11)

Name Title Board Seat Contact Info
David West Jr. Co-Founder, Chief Executive Officer & Board Member
David West Sr. Chief Operating Officer & Board Member
Coleman Stavish Co-Founder, Board Member & Chief Technology Officer
Nathan Buchbinder Co-Founder & Chief Product Officer
Michael Bonham Chief Medical Officer
You’re viewing 5 of 11 executive team members. Get the full list »

Proscia Board Members (8)

Name Representing Role Since
Alexander Niehenke Scale Venture Partners Board Member 000 0000
Charles Hazard Jr. Flybridge Capital Partners Board Member 000 0000
Christopher Gatti JD Proscia Board Member 000 0000
Coleman Stavish Proscia Co-Founder, Board Member & Chief Technology Officer 000 0000
David West Jr. Proscia Co-Founder, Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Proscia Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Proscia Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Hitachi Ventures Corporate Venture Capital Minority 000 0000 000000 0
Scale Venture Partners Venture Capital Minority 000 0000 000000 0
Flybridge Capital Partners Venture Capital Minority 000 0000 000000 0
Fusion Fund Venture Capital Minority 000 0000 000000 0
Razor's Edge Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »